Edition:
United States

People: Pluristem Therapeutics Inc (PSTI.O)

PSTI.O on Consolidated Issue listed on NASDAQ Capital Market

1.51USD
8 Dec 2016
Change (% chg)

$-0.04 (-2.58%)
Prev Close
$1.55
Open
$1.52
Day's High
$1.54
Day's Low
$1.49
Volume
148,533
Avg. Vol
135,763
52-wk High
$1.85
52-wk Low
$0.71

Ben-Yoram, Israel 

Mr. Israel Ben-Yoram is Independent Director of Pluristem Therapeutics, Inc. He has been a director and partner in the accounting firm of Mor, Ben-Yoram and Partners in Israel since 1985. In addition, since 1992, Mr. Ben-Yoram has been a shareholder and has served as the head director of Mor, Ben-Yoram Ltd., a private company in Israel in parallel to the operation of Mor, Ben-Yoram and Partners. This company provides management services, economic consulting services and other professional services to businesses. Furthermore, Mr. Ben-Yoram is the CEO of Eshed Dash Ltd. and Zonbit Ltd. During 2003-2004 Mr. Ben-Yoram served as a director of Brainstorm Cell Therapeutics Inc. (BCLI) and Smart Energy solutions, Inc. (SMGY), both of which were traded on the NASDAQ.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable 2,861,339 --
Unexercisable 5,493,750 --
Exercised -- --